Search In this Thesis
   Search In this Thesis  
العنوان
Use of PUQE (Pregnancy -Unique Quantification of Emesis) Score to Evaluate Inpatient Cases of Hyperemesis Gravidarum and Response of Treatment /
المؤلف
Abd Elmonsef, Tasnem Ibrahem Abo-Elouon,
هيئة الاعداد
باحث / Tasnem Ibrahem Abo-Elouon Abd Elmonsef
مشرف / Mohamed Mahmoud Fahmy Fathalla
مشرف / Mansour Ahmed Mohamed Khalifa
مناقش / Ahmed Mohamed Abo Elhassan
مناقش / Mahmoud Ibrahem El Molaqab
الموضوع
Obstetrics. Gynecology.
تاريخ النشر
2024.
عدد الصفحات
66 P. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
أمراض النساء والتوليد
الناشر
تاريخ الإجازة
13/3/2023
مكان الإجازة
جامعة أسيوط - كلية الطب - امراض النساء والتوليد
الفهرس
Only 14 pages are availabe for public view

from 91

from 91

Abstract

The prevalence of hyperemesis gravidarum is approximately 0.3-3% of pregnancies and varies on account of different diagnostic criteria and ethnic variation in study populations. There is a broad spectrum of nausea and vomiting of pregnancy (NVP) severity, ranging from mild, occasional nausea to severe, intractable vomiting requiring hospitalization.(Jarvis and Nelson-Piercy, 2011) Hyperemesis gravidarum (HG) is a form of severe nausea and vomiting in pregnancy (NVP) associated with significant impairment of oral intake and weight loss of at least 5% compared with pre-pregnancy, with or without dehydration and/or electrolyte abnormalities, which affects about 0.3–3.6% of pregnant women.
Admission for hyperemesis gravidarum depends on clinical impression by the attending or referring physician. There is a need for classification the severity of NVP to restrict admission to those who need admission. An objective and validated index of nausea and vomiting such as the Pregnancy-Unique Quantification of Emesis (PUQE) score may be used for this purpose. This questionnaire contains three questions regarding the time-span of nausea, vomiting and retching respectively, as well as one question assessing the global psychological and physical quality of life (QOL). Initially the questionnaire evaluated symptoms during last 12 hours, but it has been modified to encompass 24 hours as well as the whole of first trimester of pregnancy.